Labaton Sucharow has been a leader in class action litigation. In the area of securities fraud, we were among the first firms to represent a major institutional investor as lead plaintiff following passage of the Private Securities Litigation Reform Act (PSLRA), and are among the few to have successfully brought cases to trial since the act went into effect. Our antitrust attorneys pioneered the brand-name prescription drug litigation that paved the way for medical insurers and union health and welfare funds to obtain major reductions in health care costs through the use of generic alternatives. We are also recognized leaders in ERISA and consumer protection class actions.

Along the way, our goal has remained constant – find innovative ways to safeguard our clients’ rights, while adhering to the highest standards of professionalism.